Abstract:Abstract Motivation Traditional drug discovery and development are often time-consuming and high risk. Repurposing/repositioning of approved drugs offers a relatively low-cost and high-efficiency approach toward rapid development of efficacious treatments. The emergence of large-scale, heterogeneous biological networks has offered unprecedented opportunities for developing in silico drug repositioning approaches. However, capturing highly non-linear, heterogeneous network structures by most existing approaches for drug repositioning has been challenging. Results In this study, we developed a network-based deep-learning approach, termed deepDR, for in silico drug repurposing by integrating 10 networks: one drug–disease, one drug-side-effect, one drug–target and seven drug–drug networks. Specifically, deepDR learns high-level features of drugs from the heterogeneous networks by a multi-modal deep autoencoder. Then the learned low-dimensional representation of drugs together with clinically reported drug–disease pairs are encoded and decoded collectively via a variational autoencoder to infer candidates for approved drugs for which they were not originally approved. We found that deepDR revealed high performance [the area under receiver operating characteristic curve (AUROC) = 0.908], outperforming conventional network-based or machine learning-based approaches. Importantly, deepDR-predicted drug–disease associations were validated by the ClinicalTrials.gov database (AUROC = 0.826) and we showcased several novel deepDR-predicted approved drugs for Alzheimer’s disease (e.g. risperidone and aripiprazole) and Parkinson’s disease (e.g. methylphenidate and pergolide). Availability and implementation Source code and data can be downloaded from https://github.com/ChengF-Lab/deepDR Supplementary information Supplementary data are available online at Bioinformatics.

Network-Based Approaches for Drug Repositioning.

Drug Repositioning Method Based on Deep Neural Network

deepDR: a network-based deep learning approach to in silico drug repositioning

DrugRepPT: a Deep Pre-Training and Fine-Tuning Framework for Drug Repositioning Based on Drug's Expression Perturbation and Treatment Effectiveness.

A Study on Methodologies of Drug Repositioning Using Biomedical Big Data: A Focus on Diabetes Mellitus

Deep learning in target prediction and drug repositioning: Recent advances and challenges

Computational Drug Repositioning with Random Walk on a Heterogeneous Network

A comparative benchmarking and evaluation framework for heterogeneous network-based drug repositioning methods

A Review of Current In Silico Methods for Repositioning Drugs and Chemical Compounds

DRONet: effectiveness-driven drug repositioning framework using network embedding and ranking learning

A Fused Deep Learning Approach to Transform Novel Drug Repositioning

Drug repositioning based on weighted local information augmented graph neural network

Drug repositioning with adaptive graph convolutional networks

A Review of Drug Repositioning Based Chemical-induced Cell Line Expression Data

A weighted bilinear neural collaborative filtering approach for drug repositioning

Drug-Disease Association Prediction Using Heterogeneous Networks for Computational Drug Repositioning

Deep learning identifies explainable reasoning paths of mechanism of action for drug repurposing from multilayer biological network

Drug Repositioning Based on Deep Sparse Autoencoder and Drug-Disease Similarity

Deep learning for drug repurposing: Methods, databases, and applications

Network-Based Methods and Their Applications in Drug Discovery

Drug Research Meets Network Science: Where Are We?